PDGFRBeta-specific inhibitors

• 收藏
• 分享

专利权人:

ImClone LLC

发明人:

Zhu, Zhenping,Shen, Juqun

申请号：

AU2008242444

公开号：

AU2008242444B2

申请日:

2008.04.17

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

The invention is directed to novel PDGFRβ-specific antagonists. Theantagonists include antibodies, which can be bispecific. The antibodies areused to reduce or inhibit tumor growth and or to treat an angiogenic disease. Theinvention also includes combinations of PDGFRβ-specific antagonistswith VEGFR antagonists for such treatments. The antagonists can further be administeredin combination with other anti- angiogenic or anti-neoplastic drugs.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/